Purpose: To examine the relation between serum ascorbic acid (SAA), a marke
r of dietary intake (including supplements), and cause-specific mortality.
Subjects and Methods: We analyzed data from a probability sample of 8,453 A
mericans age greater than or equal to 30 years at baseline enrolled in the
Second National Health and Nutrition Examination Survey (NHANES II), who we
re followed for mortality endpoints. We calculated relative hazard ratios a
s measures of disease association comparing the mortality rates in three bi
ologically relevant SAA categories.
Results: participants with normal to high SAA levels had a marginally signi
ficant 21% to 25% decreased risk of fatal cardiovascular disease (CVD) (p f
or trend = 0.09) and a 25% to 29% decreased risk of all-cause mortality (p
for trend < 0.001) compared to participants with low levels. Because we det
ermined that gender modified the association between SAA levels and cancer
death, we analyzed these associations stratified by gender. Among men, norm
al to high SAA levels were associated with an approximately 30% decreased r
isk of cancer deaths, whereas such SAA levels were associated with an appro
ximately two-fold increased risk of cancer deaths among women. This associa
tion among women persisted even after adjustment for baseline prevalent can
cer and exclusion for early cancer death or exclusion for prevalent cancer.
Conclusions: Low SAA levels were marginally associated with an increased ri
sk of fatal CVD and significantly associated with an increased risk for all
-cause mortality. Low SAA levels were also a risk factor for cancer death i
n men, bur unexpectedly were associated with a decreased risk of cancer dea
th in women. If the association between low SAA levels and all-cause mortal
ity is causal, increasing the consumption of ascorbic acid, and thereby SAA
levels, could decrease the risk of death among Americans with low ascorbic
acid intakes.